Kuan-Chun Huang

Kuan-Chun Huang is an experienced professional in the fields of pharmacology and translational science, currently serving as Senior Director at PharmaEssentia since November 2022. Prior roles include Director and Associate Director in Immuno-Oncology and Pharmacology at H3 Biomedicine from January 2019 to November 2022, and various senior scientific positions at Eisai Inc and AiM Institute between 2006 and 2018. Kuan-Chun Huang began a career in research as a Post-doctoral Fellow at Brigham and Women's Hospital, focusing on ovarian cancer early diagnostic and prognostic biomarker research. Educational credentials include a PhD in Medical Microbiology and Immunology from The Ohio State University, earned in January 1999.